Sentry Investment Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-434
Closed -$26K 432
2025
Q4
$26K Hold
434
0.02% 489
2025
Q3
$26K Sell
434
-53
-11% -$2.84K 0.02% 500
2025
Q2
$26K Hold
487
0.01% 478
2025
Q1
$25K Sell
487
-145
-23% -$9.83K 0.02% 457
2024
Q4
$46K Sell
632
-103
-14% -$7.56K 0.02% 416
2024
Q3
$59K Buy
+735
New +$55.2K 0.02% 423
2024
Q2
Sell
-826
Closed -$58K 468
2024
Q1
$58K Hold
826
0.02% 414
2023
Q4
$64K Sell
826
-89
-10% -$5.86K 0.03% 414
2023
Q3
$62K Sell
915
-53
-5% -$4.19K 0.03% 437
2023
Q2
$79K Hold
968
0.03% 431
2023
Q1
$72K Sell
968
-2,661
-73% -$205K 0.03% 422
2022
Q4
$301K Buy
3,629
+2,041
+129% +$162K 0.13% 175
2022
Q3
$113K Buy
1,588
+544
+52% +$47K 0.05% 339
2022
Q2
$90K Sell
1,044
-204
-16% -$19.1K 0.04% 394
2022
Q1
$135K Sell
1,248
-208
-14% -$21.5K 0.04% 370
2021
Q4
$188K Buy
1,456
+292
+25% +$35.8K 0.05% 335
2021
Q3
$141K Buy
+1,164
New +$142K 0.04% 388

Other funds holding TECH

Sentry Investment Management's TECH Position: Q1 2026 in Review

Sentry Investment Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 434 shares — an estimated $26K sold.

Sentry Investment Management first reported a position in TECH in Q3 2021 and held it in 17 quarters. The position peaked at $301K in Q4 2022. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Sentry Investment Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 434 Bio-Techne shares in Q1 2026, an estimated $26K.
  • Sentry Investment Management first reported a position in Bio-Techne in Q3 2021 and held it in 17 quarters.
  • Sentry Investment Management's Bio-Techne position peaked at $301K in Q4 2022.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.